Menu

Working Group

« View all

Modeling & Simulation Workgroup (M&S-WG) Q4-2015 Update

Working closely with the Data Standards and Integration Workgroup (DSI-WG), the M&S-WG uses aggregated clinical trial data to create robust empirical, mechanistic, and systems biology models and quantitative simulation tools to facilitate TB drug and drug regimen development.

Objectives:                                            

Many critical translational gaps exist in the science of TB drug regimen development. The Modeling and Simulation Workgroup is comprised of multiple partnerships designed to develop models that address some of the current limitations in TB combination drug development.  For a complete list of objectives, see Appendix A.

4Q, 2015 Progress:

« View all